Home › Companies › BICYCLE THERAPEUTICS PLC › 2023-2024

BICYCLE THERAPEUTICS PLC 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and BICYCLE THERAPEUTICS PLC’s Form 8-K, filed 2024-05-16 (Item 5.07 on EDGAR). Page generated 02 October 2026.

12Reported items
100Asset managers
450Fund votes
2024-05-16Meeting date

Proxy season: 2023-2024 2024-2025

Explore BICYCLE THERAPEUTICS PLC in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by BICYCLE THERAPEUTICS PLC

These tallies are BICYCLE THERAPEUTICS PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-16 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BICYCLE THERAPEUTICS PLC — official shareholder meeting results, meeting held 2024-05-16
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Proposal 1: To re-elect as a director Kevin Lee.	36,413,260	977,286	7,561	7,561	--	Majority: yes
Proposal 2: To re-elect as a director Jose-Carlos Gutierrez-Ramos.	35,019,069	2,371,385	7,653	7,653	--	Majority: yes
Proposal 3: To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement.	36,186,115	1,202,477	9,515	9,515	--	Majority: yes
Proposal 4: To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.S	37,376,526	14,076	7,505	7,505	--	Majority: yes
Proposal 5: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K	37,376,531	14,071	7,505	7,505	--	Majority: yes
Proposal 6: To authorize the Audit Committee of the Company's Board of Directors (the "Board") to determine the Company's U.K	37,376,455	14,150	7,502	7,502	--	Majority: yes
Proposal 7: To receive and adopt the Company's U.K	36,494,043	896,166	7,898	7,898	--	Majority: yes
Proposal 8: To approve the directors' remuneration report for the year ended December 31, 2023.	36,200,790	1,188,057	9,260	9,260	--	Majority: yes
Proposal 9: To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000.	33,241,556	4,146,578	9,973	9,973	--	Majority: yes
Proposal 10: To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K	32,350,797	4,154,715	892,595	892,595	--	Majority: yes
Proposal 11: To adopt the new articles of association in substitution for, and to the exclusion of, the Company's existing articles of association.	37,371,711	15,138	11,258	11,258	--	Majority: yes

Source: BICYCLE THERAPEUTICS PLC, Form 8-K, filed with the SEC on 2024-05-16 — read the filing on EDGAR.

How asset managers voted at the BICYCLE THERAPEUTICS PLC 2023-2024 meeting

Each item below shows how the 100 asset managers that disclosed a BICYCLE THERAPEUTICS PLC vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BICYCLE THERAPEUTICS PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 36,186,115AGAINST: 1,202,477

BICYCLE THERAPEUTICS PLC’s own tally for this item (“Proposal 3: To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement.”): 36,186,115 for, 1,202,477 against, per its Form 8-K filed 2024-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 99 asset managers below cast 98% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 98%

FOR: 97.9%AGAINST: 2.1%ABSTAIN: 0.0%NOT VOTED: 0.0%

Largest asset managers voting on “To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy sta” at BICYCLE THERAPEUTICS PLC, 2023-2024
Asset manager	For	Against	Vote
New York Life	29,000,000	0	For
BAKER BROS. ADVISORS LP	6,437,592	0	For
Deep Track Capital, LP	3,441,487	0	For
Paradigm Biocapital Advisors LP	1,902,346	0	For
TYBOURNE CAPITAL MANAGEMENT (HK) LTD	1,545,026	0	For
ARMISTICE CAPITAL, LLC	1,413,513	0	For
First Light Asset Management, LLC	1,160,315	0	For
Polar Capital Holdings Plc	1,004,535	0	For
Candriam S.C.A.	948,157	0	For
BNP Paribas Asset Management Holding S.A.	0	883,105	Against
SUVRETTA CAPITAL MANAGEMENT, LLC	822,945	0	For
RA CAPITAL MANAGEMENT, L.P.	800,000	0	For
WESTFIELD CAPITAL MANAGEMENT CO LP	765,757	0	For
T. Rowe Price	727,260	0	For
HARBOR FUNDS	484,785	0	For
BlackRock	412,471	0	For
Camber Capital Management LP	408,201	0	For
Verition Fund Management LLC	338,792	0	For
PLATINUM INVESTMENT MANAGEMENT LTD	316,165	0	For
Duquesne Family Office LLC	190,200	0	For
Allianz	0	184,645	Against
KENNEDY CAPITAL MANAGEMENT LLC	174,115	0	For
Soleus Capital Management, L.P.	140,800	0	For
Rubric Capital Management LP	121,102	0	For
HighVista Strategies LLC	102,289	0	For

Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.

2. To approve our directors' remuneration report for the year ended December 31, 2023 (the "directors' remuneration report"), which is set forth as Annex A to the proxy statement

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 36,200,790AGAINST: 1,188,057

BICYCLE THERAPEUTICS PLC’s own tally for this item (“Proposal 8: To approve the directors' remuneration report for the year ended December 31, 2023.”): 36,200,790 for, 1,188,057 against, per its Form 8-K filed 2024-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 49 asset managers below cast 100% of the shares they voted on this item FOR (14,597,527 for, 0 against).

FOR 99.9%

FOR: 14,597,527 (100.0%)ABSTAIN: 7,200 (0.0%)

Largest asset managers voting on “To approve our directors' remuneration report for the year ended December 31, 2023 (the "directors' remunerati” at BICYCLE THERAPEUTICS PLC, 2023-2024
Asset manager	For	Abstain	Vote
BAKER BROS. ADVISORS LP	6,437,592	0	For
Deep Track Capital, LP	3,441,487	0	For
TYBOURNE CAPITAL MANAGEMENT (HK) LTD	1,545,026	0	For
ARMISTICE CAPITAL, LLC	1,413,513	0	For
HARBOR FUNDS	484,785	0	For
BlackRock	389,646	0	For
T. Rowe Price	325,779	0	For
Soleus Capital Management, L.P.	140,800	0	For
Rubric Capital Management LP	121,102	0	For
MUTUAL FUND SERIES TRUST	60,000	0	For
PINNACLE ASSOCIATES LTD	30,450	0	For
State Street	29,361	0	For
WOODSTOCK CORP	24,981	0	For
Harbor Funds II	19,236	0	For
Fidelity	17,277	0	For
Harbor ETF Trust	16,364	0	For
John Hancock	16,128	0	For
Listed Funds Trust	14,396	0	For
ETF Series Solutions	12,512	0	For
DWS	8,070	0	For
Morgan Stanley	7,920	0	For
Twelve Points Wealth Management LLC	0	7,200	Abstain
Natixis	6,067	0	For
ETFis Series Trust I	5,774	0	For
Equitable	4,560	0	For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

3. Special Resolutions To empower the Board of Directors to allot equity securities for cash up to a maximum aggregate nominal amount of pounds1,000,000 pursuant to the authorization in Resolution 9 as if U.K. statutory pre-emption rights did not apply

CAPITAL STRUCTUREMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%11%

FOR: 32,350,797AGAINST: 4,154,715

BICYCLE THERAPEUTICS PLC’s own tally for this item (“Proposal 10: To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K”): 32,350,797 for, 4,154,715 against, per its Form 8-K filed 2024-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 21 asset managers below cast 84% of the shares they voted on this item FOR (2,166,133 for, 412,420 against).

FOR 84%AGAINST 16%

FOR: 2,166,133 (84.0%)AGAINST: 412,420 (16.0%)

Largest asset managers voting on “Special Resolutions To empower the Board of Directors to allot equity securities for cash up to a maximum aggr” at BICYCLE THERAPEUTICS PLC, 2023-2024
Asset manager	For	Against	Vote
First Light Asset Management, LLC	1,160,315	0	For
HARBOR FUNDS	484,785	0	For
BlackRock	389,646	0	For
T. Rowe Price	0	325,779	Against
MUTUAL FUND SERIES TRUST	60,000	0	For
State Street	26,773	2,588	For
Harbor Funds II	19,236	0	For
Fidelity	0	17,277	Against
Harbor ETF Trust	16,364	0	For
John Hancock	0	16,128	Against
Listed Funds Trust	0	14,396	Against
ETF Series Solutions	0	12,512	Against
DWS	0	8,070	Against
Morgan Stanley	7,920	0	For
ETFis Series Trust I	0	5,774	Against
Equitable	0	4,560	Against
Blackstone Alternative Investment Funds	0	2,600	Against
ProShares	0	2,481	Against
TRUST FOR PROFESSIONAL MANAGERS	1,094	0	For
Invesco	0	129	Against
Investment Managers Series Trust II	0	126	Against

4. To authorize the Board of Directors to allot shares or to grant rights to subscribe for or convert any security into shares up to a maximum aggregate nominal amount of pounds1,000,000

CAPITAL STRUCTUREMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%11%

FOR: 33,241,556AGAINST: 4,146,578

BICYCLE THERAPEUTICS PLC’s own tally for this item (“Proposal 9: To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000.”): 33,241,556 for, 4,146,578 against, per its Form 8-K filed 2024-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 21 asset managers below cast 84% of the shares they voted on this item FOR (2,166,133 for, 412,420 against).

FOR 84%AGAINST 16%

FOR: 2,166,133 (84.0%)AGAINST: 412,420 (16.0%)

Largest asset managers voting on “To authorize the Board of Directors to allot shares or to grant rights to subscribe for or convert any securit” at BICYCLE THERAPEUTICS PLC, 2023-2024
Asset manager	For	Against	Vote
First Light Asset Management, LLC	1,160,315	0	For
HARBOR FUNDS	484,785	0	For
BlackRock	389,646	0	For
T. Rowe Price	0	325,779	Against
MUTUAL FUND SERIES TRUST	60,000	0	For
State Street	26,773	2,588	For
Harbor Funds II	19,236	0	For
Fidelity	0	17,277	Against
Harbor ETF Trust	16,364	0	For
John Hancock	0	16,128	Against
Listed Funds Trust	0	14,396	Against
ETF Series Solutions	0	12,512	Against
DWS	0	8,070	Against
Morgan Stanley	7,920	0	For
ETFis Series Trust I	0	5,774	Against
Equitable	0	4,560	Against
Blackstone Alternative Investment Funds	0	2,600	Against
ProShares	0	2,481	Against
TRUST FOR PROFESSIONAL MANAGERS	1,094	0	For
Invesco	0	129	Against
Investment Managers Series Trust II	0	126	Against

5. Ordinary Resolutions To re-elect as a director Kevin Lee, who retires in accordance with the Articles of Association

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 36,413,260AGAINST: 977,286

BICYCLE THERAPEUTICS PLC’s own tally for this item (“Proposal 1: To re-elect as a director Kevin Lee.”): 36,413,260 for, 977,286 against, per its Form 8-K filed 2024-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 20 asset managers below cast 100% of the shares they voted on this item FOR (1,418,238 for, 0 against).

FOR 100%

FOR: 1,418,238 (100.0%)

Largest asset managers voting on “Ordinary Resolutions To re-elect as a director Kevin Lee, who retires in accordance with the Articles of Assoc” at BICYCLE THERAPEUTICS PLC, 2023-2024
Asset manager	For	Vote
HARBOR FUNDS	484,785	For
BlackRock	389,646	For
T. Rowe Price	325,779	For
MUTUAL FUND SERIES TRUST	60,000	For
State Street	29,361	For
Harbor Funds II	19,236	For
Fidelity	17,277	For
Harbor ETF Trust	16,364	For
John Hancock	16,128	For
Listed Funds Trust	14,396	For
ETF Series Solutions	12,512	For
DWS	8,070	For
Morgan Stanley	7,920	For
ETFis Series Trust I	5,774	For
Equitable	4,560	For
Blackstone Alternative Investment Funds	2,600	For
ProShares	2,481	For
TRUST FOR PROFESSIONAL MANAGERS	1,094	For
Invesco	129	For
Investment Managers Series Trust II	126	For

6. To adopt new articles of association, which are set forth in Annex B to the proxy statement

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 37,371,711AGAINST: 15,138

BICYCLE THERAPEUTICS PLC’s own tally for this item (“Proposal 11: To adopt the new articles of association in substitution for, and to the exclusion of, the Company's existing articles of association.”): 37,371,711 for, 15,138 against, per its Form 8-K filed 2024-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 20 asset managers below cast 100% of the shares they voted on this item FOR (1,418,238 for, 0 against).

FOR 100%

FOR: 1,418,238 (100.0%)

Largest asset managers voting on “To adopt new articles of association, which are set forth in Annex B to the proxy statement” at BICYCLE THERAPEUTICS PLC, 2023-2024
Asset manager	For	Vote
HARBOR FUNDS	484,785	For
BlackRock	389,646	For
T. Rowe Price	325,779	For
MUTUAL FUND SERIES TRUST	60,000	For
State Street	29,361	For
Harbor Funds II	19,236	For
Fidelity	17,277	For
Harbor ETF Trust	16,364	For
John Hancock	16,128	For
Listed Funds Trust	14,396	For
ETF Series Solutions	12,512	For
DWS	8,070	For
Morgan Stanley	7,920	For
ETFis Series Trust I	5,774	For
Equitable	4,560	For
Blackstone Alternative Investment Funds	2,600	For
ProShares	2,481	For
TRUST FOR PROFESSIONAL MANAGERS	1,094	For
Invesco	129	For
Investment Managers Series Trust II	126	For

7. To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending December 31, 2024

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 20 asset managers below cast 100% of the shares they voted on this item FOR (1,418,238 for, 0 against).

FOR: 1,418,238 (100.0%)

Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the l” at BICYCLE THERAPEUTICS PLC, 2023-2024
Asset manager	For	Vote
HARBOR FUNDS	484,785	For
BlackRock	389,646	For
T. Rowe Price	325,779	For
MUTUAL FUND SERIES TRUST	60,000	For
State Street	29,361	For
Harbor Funds II	19,236	For
Fidelity	17,277	For
Harbor ETF Trust	16,364	For
John Hancock	16,128	For
Listed Funds Trust	14,396	For
ETF Series Solutions	12,512	For
DWS	8,070	For
Morgan Stanley	7,920	For
ETFis Series Trust I	5,774	For
Equitable	4,560	For
Blackstone Alternative Investment Funds	2,600	For
ProShares	2,481	For
TRUST FOR PROFESSIONAL MANAGERS	1,094	For
Invesco	129	For
Investment Managers Series Trust II	126	For

8. To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 37,376,531AGAINST: 14,071

BICYCLE THERAPEUTICS PLC’s own tally for this item (“Proposal 5: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K”): 37,376,531 for, 14,071 against, per its Form 8-K filed 2024-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 20 asset managers below cast 100% of the shares they voted on this item FOR (1,418,238 for, 0 against).

FOR 100%

FOR: 1,418,238 (100.0%)

Largest asset managers voting on “To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England,” at BICYCLE THERAPEUTICS PLC, 2023-2024
Asset manager	For	Vote
HARBOR FUNDS	484,785	For
BlackRock	389,646	For
T. Rowe Price	325,779	For
MUTUAL FUND SERIES TRUST	60,000	For
State Street	29,361	For
Harbor Funds II	19,236	For
Fidelity	17,277	For
Harbor ETF Trust	16,364	For
John Hancock	16,128	For
Listed Funds Trust	14,396	For
ETF Series Solutions	12,512	For
DWS	8,070	For
Morgan Stanley	7,920	For
ETFis Series Trust I	5,774	For
Equitable	4,560	For
Blackstone Alternative Investment Funds	2,600	For
ProShares	2,481	For
TRUST FOR PROFESSIONAL MANAGERS	1,094	For
Invesco	129	For
Investment Managers Series Trust II	126	For

9. To re-elect as a director Jose-Carlos Gutierrez-Ramos, who retires in accordance with the Articles of Association

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%

FOR: 35,019,069AGAINST: 2,371,385

BICYCLE THERAPEUTICS PLC’s own tally for this item (“Proposal 2: To re-elect as a director Jose-Carlos Gutierrez-Ramos.”): 35,019,069 for, 2,371,385 against, per its Form 8-K filed 2024-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 20 asset managers below cast 99.9% of the shares they voted on this item FOR (1,418,109 for, 129 against).

FOR 99.9%

FOR: 1,418,109 (100.0%)AGAINST: 129 (0.0%)

Largest asset managers voting on “To re-elect as a director Jose-Carlos Gutierrez-Ramos, who retires in accordance with the Articles of Associat” at BICYCLE THERAPEUTICS PLC, 2023-2024
Asset manager	For	Against	Vote
HARBOR FUNDS	484,785	0	For
BlackRock	389,646	0	For
T. Rowe Price	325,779	0	For
MUTUAL FUND SERIES TRUST	60,000	0	For
State Street	29,361	0	For
Harbor Funds II	19,236	0	For
Fidelity	17,277	0	For
Harbor ETF Trust	16,364	0	For
John Hancock	16,128	0	For
Listed Funds Trust	14,396	0	For
ETF Series Solutions	12,512	0	For
DWS	8,070	0	For
Morgan Stanley	7,920	0	For
ETFis Series Trust I	5,774	0	For
Equitable	4,560	0	For
Blackstone Alternative Investment Funds	2,600	0	For
ProShares	2,481	0	For
TRUST FOR PROFESSIONAL MANAGERS	1,094	0	For
Invesco	0	129	Against
Investment Managers Series Trust II	126	0	For

10. To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2023 (the "2023 U.K. Annual Report")

CORPORATE GOVERNANCE

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 20 asset managers below cast 100% of the shares they voted on this item FOR (1,418,238 for, 0 against).

FOR: 1,418,238 (100.0%)

Largest asset managers voting on “To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2023 (the ” at BICYCLE THERAPEUTICS PLC, 2023-2024
Asset manager	For	Vote
HARBOR FUNDS	484,785	For
BlackRock	389,646	For
T. Rowe Price	325,779	For
MUTUAL FUND SERIES TRUST	60,000	For
State Street	29,361	For
Harbor Funds II	19,236	For
Fidelity	17,277	For
Harbor ETF Trust	16,364	For
John Hancock	16,128	For
Listed Funds Trust	14,396	For
ETF Series Solutions	12,512	For
DWS	8,070	For
Morgan Stanley	7,920	For
ETFis Series Trust I	5,774	For
Equitable	4,560	For
Blackstone Alternative Investment Funds	2,600	For
ProShares	2,481	For
TRUST FOR PROFESSIONAL MANAGERS	1,094	For
Invesco	129	For
Investment Managers Series Trust II	126	For

11. To authorize the Audit Committee to determine our U.K. statutory 31,2024 auditors' remuneration for the year ending December 31, 2024

AUDIT-RELATEDMajority of the votes cast: yes

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 37,376,455AGAINST: 14,150

BICYCLE THERAPEUTICS PLC’s own tally for this item (“Proposal 6: To authorize the Audit Committee of the Company's Board of Directors (the "Board") to determine the Company's U.K”): 37,376,455 for, 14,150 against, per its Form 8-K filed 2024-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 13 asset managers below cast 100% of the shares they voted on this item FOR (808,119 for, 0 against).

FOR 100%

FOR: 808,119 (100.0%)

Largest asset managers voting on “To authorize the Audit Committee to determine our U.K. statutory 31,2024 auditors' remuneration for the year e” at BICYCLE THERAPEUTICS PLC, 2023-2024
Asset manager	For	Vote
BlackRock	389,646	For
T. Rowe Price	325,779	For
State Street	29,361	For
Fidelity	17,277	For
Listed Funds Trust	14,396	For
DWS	8,070	For
Morgan Stanley	7,920	For
ETFis Series Trust I	5,774	For
Equitable	4,560	For
Blackstone Alternative Investment Funds	2,600	For
ProShares	2,481	For
Invesco	129	For
Investment Managers Series Trust II	126	For

12. To authorize the Audit Committee to determine our U.K. statutory auditors' remuneration for the year ending December 31, 2024

AUDIT-RELATEDMajority of the votes cast: yes

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 37,376,455AGAINST: 14,150

The 7 asset managers below cast 100% of the shares they voted on this item FOR (610,119 for, 0 against).

FOR 100%

FOR: 610,119 (100.0%)

Largest asset managers voting on “To authorize the Audit Committee to determine our U.K. statutory auditors' remuneration for the year ending De” at BICYCLE THERAPEUTICS PLC, 2023-2024
Asset manager	For	Vote
HARBOR FUNDS	484,785	For
MUTUAL FUND SERIES TRUST	60,000	For
Harbor Funds II	19,236	For
Harbor ETF Trust	16,364	For
John Hancock	16,128	For
ETF Series Solutions	12,512	For
TRUST FOR PROFESSIONAL MANAGERS	1,094	For

Largest BICYCLE THERAPEUTICS PLC shareholders voting in 2023-2024

Ranked by the number of BICYCLE THERAPEUTICS PLC shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 30,043,486 shares outstanding at the time of that meeting.

Top BICYCLE THERAPEUTICS PLC shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	New York Life	96.53%
2	BAKER BROS. ADVISORS LP	21.43%
3	Deep Track Capital, LP	11.46%
4	Paradigm Biocapital Advisors LP	6.33%
5	TYBOURNE CAPITAL MANAGEMENT (HK) LTD	5.14%
6	ARMISTICE CAPITAL, LLC	4.70%
7	First Light Asset Management, LLC	3.86%
8	Polar Capital Holdings Plc	3.34%
9	Candriam S.C.A.	3.16%
10	BNP Paribas Asset Management Holding S.A.	2.94%

Reported BICYCLE THERAPEUTICS PLC ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

BICYCLE THERAPEUTICS PLC beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
Paradigm BioCapital Advisors LP	12.34%	13G
Morgan Stanley	2.74%	13F
T. Rowe Price	1.34%	13F
Point72	1.14%	13F
BlackRock	0.94%	13F
Renaissance Technologies	0.55%	13F
Citadel Advisors	0.26%	13F
Two Sigma	0.10%	13F
State Street	0.09%	13F
Geode Capital	0.07%	13F

Percentages above are of 30,043,486 shares outstanding, as reported by BICYCLE THERAPEUTICS PLC on its Form 10-Q dated 2023-05-01 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BICYCLE THERAPEUTICS PLC’s 10-Q dated 2023-05-01. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At BICYCLE THERAPEUTICS PLC's shareholder meeting held 2024-05-16, in the 2023-2024 proxy season, 100 asset managers reported how they voted in their SEC Form N-PX filings, covering 450 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on advisory basis, the compensation of our named executive officers, as disclosed… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BICYCLE THERAPEUTICS PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-16.

BICYCLE THERAPEUTICS PLC proxy season coverage: 2023-2024 (this page) · 2024-2025.